MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
98.00
-5.00
-4.85%
Closed 12:51 12/05 EST
OPEN
98.00
PREV CLOSE
103.00
HIGH
98.00
LOW
98.00
VOLUME
100
TURNOVER
9.80K
52 WEEK HIGH
113.54
52 WEEK LOW
89.72
MARKET CAP
119.28B
P/E (TTM)
21.85
1D
5D
1M
3M
1Y
5Y
1D
Bernstein Sticks to Its Buy Rating for Sanofi (SNYNF)
TipRanks · 1d ago
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
TipRanks · 1d ago
FDA shift in drug study requirements sends trial runners lower
TipRanks · 2d ago
FDA to reduce number of trials required for drug approvals, STAT reports
TipRanks · 2d ago
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
TipRanks · 4d ago
Vaccine committee considers changes to childhood schedule, NY Times reports
TipRanks · 4d ago
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
TipRanks · 5d ago
Prasad email a headwind for vaccine manufacturers, says BofA
TipRanks · 5d ago
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.